XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income $ 97,315 $ 45,648
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization of premises and equipment 2,832 3,102
(Reversal of) provision for credit losses (6,315) 36,000
Amortization of intangibles 1,498 1,931
Net accretion of loans (4,130) (5,225)
Accretion on bank premises (61) (68)
Accretion on deposits (1,762) (3,568)
Accretion on borrowings, net (43) (139)
Stock-based compensation 3,202 1,999
Gains on sales/redemptions of securities available-for-sale, net (195) (29)
Losses (gains) on equity securities, net 242 (215)
Gain on sale of branches (674)
Net losses on disposition of fixed assets 65
Gains on sales of loans held-for-sale, net (2,668) (1,244)
Loans originated for resale (43,676) (34,328)
Proceeds from sale of loans held-for sale 57,674 51,367
Gain on sale of other real estate owned (18)
Increase in cash surrender value of bank owned life insurance (3,527) (3,693)
Amortization of premiums and accretion of discounts on securities available-for-sale, net 4,677 4,000
Amortization of subordinated debentures issuance costs 227 247
Decrease (increase) in accrued interest receivable 1,707 (10,467)
Net change in operating leases (734) 2,071
Decrease in other assets 43,319 18,117
Increase (decrease) in other liabilities 5,689 (5,750)
Net cash provided by operating activities 154,644 99,756
Cash flows from investing activities    
Purchases (203,534) (222,062)
Sales 19,624
Maturities, calls and principal repayments 215,531 175,729
Purchases of equity securities (555) (2,000)
Net redemptions of restricted investment in bank stocks 6,993 1,748
Net increase in loans (345,098) (348,861)
Purchases of bank owned life insurance (25,000) (25,000)
Purchases of premises and equipment (2,473) (894)
Payments on loans held-for-sale 32 204
Proceeds from life insurance death benefits 978
Proceeds from sale of branches 1,087
Proceeds from sale of other real estate owned 321 992
Cash and cash equivalents acquired in acquisition, net 87,391
Net cash used in investing activities (352,696) (312,151)
Cash flows from financing activities    
Net increase in deposits 440,876 249,404
(Repayment of) increase in subordinated debentures (50,000) 73,420
Advances of borrowings 100,000 1,476,489
Repayments of borrowings (272,686) (1,520,160)
Repurchase of common stock to treasury (8,043) (911)
Net proceeds from the issuance of preferred stock 110,927
Cash dividends paid on common stock (12,345) (10,735)
Proceeds from exercise of stock options 45 163
Share redemption for tax withholdings on performance units and restricted stock units earned (1,283) (639)
Net cash provided by financing activities 307,491 267,031
Net change in cash and cash equivalents 109,439 54,636
Cash and cash equivalents at beginning of period 303,756 201,483
Cash and cash equivalents at end of period 413,195 256,119
Cash payments for:    
Interest paid on deposits and borrowings 32,664 59,231
Income taxes 35,809 19,117
Investing:    
Transfer of loans from held-for-investment to other real estate owned 304
Transfer of loans from held-for-investment to held-for-sale 14,211 10,995
Transfer of loans from held-for-sale to held-for-investment 1,963 19,738
Business combinations:    
Fair value of assets acquired 949,282
Fair value of liabilities assumed $ 852,729